collection of cells

Life Sciences Investment Programme

We seek best-in-class fund managers with a UK focus.

Through the Life Sciences Investment Programme, British Patient Capital has been allocated an additional £200m to make cornerstone commitments to later stage life sciences venture growth funds. This is expected to attract at least a further £400m of private investment, ensuring the UK continues to be a world leader in health and life sciences innovation.

British Patient Capital intends to invest between £50 and £100 million in each successful fund.

image of employee writing

What we look for

  • Dedicated life sciences focus
  • Funds providing later-stage capital
  • UK presence in investment team
  • Minimum target fund size of £250m
  • Focus on funding UK companies

Find out more

For further information please see our Request for Proposals

If you have any queries please contact